Effect of BG-12 (dimethyl fumarate) in newly diagnosed patients with relapsing-remitting multiple sclerosis from the DEFINE and CONFIRM studies

被引：0
|
作者：
Gold, R.
Giovannoni, G.
Phillips, J. T.
Fox, R. J.
Zhang, A.
Meltzer, L.
Kurukulasuriya, N. C.
机构：
[1] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
[2] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[3] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[4] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[5] Biogen Idec Inc, Weston, MA USA
来源：
JOURNAL OF NEUROLOGY | 2013年 / 260卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O327
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [21] Clinical and Neuroradiologic Efficacy of BG-12 (Dimethyl Fumarate) in US Patients with Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Kita, Mariko
    Fox, Robert
    Phillips, J. Theodore
    Arnold, Douglas
    Bar-Or, Amit
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine
    Viglietta, Vissia
    Sheikh, Sarah
    Gold, Ralf
    NEUROLOGY, 2013, 80
  • [22] Clinical Efficacy and Safety of Oral Bg-12 (Dimethyl Fumarate) In Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 Define and Confirm Studies
    Bar-Or, A.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Selmaj, K.
    Kurukulasuriya, N. C.
    Yang, M.
    Raghupathi, K.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1828 - 1828
  • [23] Advances in the management of relapsing-remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12)
    Nielsen, A. Scott
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2015, 5
  • [24] THE COST EFFECTIVENESS OF BG-12 (DIMETHYL FUMARATE) FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CANADA
    Su, W.
    Walker, A.
    Sarda, S.
    Kansal, A. R.
    Vicente, C.
    Deniz, B.
    VALUE IN HEALTH, 2013, 16 (07) : A623 - A623
  • [25] Effect of BG-12 in Subgroups of Patients with Relapsing-Remitting Multiple Sclerosis: Findings from the DEFINE Study
    Bar-Or, Amit
    Gold, Ralf
    Kappos, Ludwig
    Arnold, Douglas
    Giovannoni, Gavin
    Selmaj, Krzysztof
    O'Gorman, John
    Stephan, Monica
    Dawson, Katherine
    NEUROLOGY, 2012, 78
  • [26] Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study
    Havrdova, E.
    Phillips, J. T.
    Fox, R. J.
    Miller, D.
    Kita, M.
    Hutchinson, M.
    Raghupathi, K.
    Yuan, H.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    JOURNAL OF NEUROLOGY, 2012, 259 : S105 - S105
  • [27] Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis
    Ruggieri, Serena
    Tortorella, Carla
    Gasperini, Claudio
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 229 - 239
  • [28] Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing–remitting multiple sclerosis: subgroup analyses of the CONFIRM study
    Michael Hutchinson
    Robert J. Fox
    David H. Miller
    J. Theodore Phillips
    Mariko Kita
    Eva Havrdova
    John O’Gorman
    Ray Zhang
    Mark Novas
    Vissia Viglietta
    Katherine T. Dawson
    Journal of Neurology, 2013, 260 : 2286 - 2296
  • [29] Clinical Efficacy of BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis (RRMS) According to Prior Therapy: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Hutchinson, Michael
    Gold, Ralf
    Fox, Robert
    Havrdova, Eva
    Giovannoni, Gavin
    Zhang, Annie
    Hotermans, Christophe
    Stephan, Monica
    Dawson, Katherine
    Bar-Or, Amit
    NEUROLOGY, 2013, 80
  • [30] Clinical efficacy of BG-12 in relapsing-remitting multiple sclerosis: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Gold, R.
    Miller, D. H.
    Phillips, J. T.
    Arnold, D. L.
    Selmaj, K.
    Yang, M.
    Zhang, R.
    Dawson, K. T.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 48 - 49
12345